KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other financing activities (2016)

Jazz Pharmaceuticals has reported Other financing activities over the past 5 years, most recently at -$3.5 million for Q3 2016.

  • Quarterly results put Other financing activities at -$3.5 million for Q3 2016, down 994.69% from a year ago — trailing twelve months through Sep 2016 was $320000.0 (up 112.53% YoY), and the annual figure for FY2014 was $1.8 million, changed.
  • Other financing activities for Q3 2016 was -$3.5 million at Jazz Pharmaceuticals, up from -$4.4 million in the prior quarter.
  • Over the last five years, Other financing activities for JAZZ hit a ceiling of $10.6 million in Q1 2015 and a floor of -$10.6 million in Q2 2015.
  • Median Other financing activities over the past 5 years was $320000.0 (2015), compared with a mean of $741000.0.
  • Biggest five-year swings in Other financing activities: skyrocketed 3903.66% in 2014 and later plummeted 994.69% in 2016.
  • Jazz Pharmaceuticals' Other financing activities stood at $5.5 million in 2012, then tumbled by 98.51% to $82000.0 in 2013, then tumbled by 2824.39% to -$2.2 million in 2014, then skyrocketed by 114.32% to $320000.0 in 2015, then crashed by 1194.69% to -$3.5 million in 2016.
  • The last three reported values for Other financing activities were -$3.5 million (Q3 2016), -$4.4 million (Q2 2016), and $7.9 million (Q1 2016) per Business Quant data.